Wolfe Research reiterates Darden stock Outperform rating at $220

Comparable sales rose 4.2% overall with LongHorn same-store sales up 7.2%; management guided Q4 same-store sales growth of 3.5%–5%. Analysts reacted positively — Wolfe Research reiterated Outperform with a $220 target while Evercore, KeyBanc, Morgan Stanley and BTIG set higher targets ($230, $226, $236, $225 respectively). The company shows 8.51% revenue growth over the last 12 months, trades at a P/E of 21.33, and yields 2.94% with InvestingPro rating its financial health as "GOOD". Wolfe cited scale, strong management and potential M&A as upside drivers.

Analysis

Darden’s platform gives it optionality beyond single-brand sales — scale on protein and produce buys can compress cost-of-goods volatility by an incremental 100–300bps versus midsize peers in a year of commodity swings, enabling targeted margin-funded promotions without binary hit to operating margins. That creates a path for EPS upside that is driven more by margin capture and capital allocation (buybacks / tuck-ins) than by same-store-sales alone, shortening the time horizon for re-rating to 6–12 months if management levers allocation toward share repurchase when yields on buybacks exceed store-level returns.

The biggest second-order beneficiary is brand-level traffic economics: stronger chain-level loyalty and cross-brand gift-card flows reduce marketing CAC and raise customer lifetime value, pressuring independents and small public casual-dining chains to either discount or increase capex on digital. Conversely, a macro jolt (sharper unemployment, real wage decline, or beef-price spike) would transmit faster to lower-end fast-casual and independents than to a diversified multi-format operator, which raises asymmetric downside protection for scale players over 3–12 months.

Key near-term risks are policy and input shocks rather than execution: a longer-for-longer Fed keeps cost of capital high, trimming buyback optionality and compressing multiple expansion; a cattle or labor-cost shock could erase expected margin tailwinds within a single quarter. Watch 1–3 quarter cadence: sustained margin realization and opportunistic M&A will validate the bullish path; failure to convert purchasing scale into incremental EBITDA or a conservative capital-return stance would be the quickest catalyst to unwind the premium.

Key Decisions for Investors

• Initiate an overweight in DRI (size 3–5% of liquid equity sleeve) within 30 days; target +25–35% total return over 6–12 months if margin/capital-allocation levers are deployed. Use a hard stop at -10–12% to limit drawdown; thesis fails if buyback activity stalls or commodity inflation reappears.
• Buy a 9–12 month DRI call spread (buy ATM, sell ~+12–15% OTM) to gain asymmetric upside with defined downside (premium). This structure targets ~2–3x payoff if the market re-rates on margin realization or a small accretive acquisition; max loss = premium paid, breakeven requiring ~+8–12% share move.
• Pair trade: long DRI / short EAT (Brinker) or small-cap casual-dining exposure (0.6–0.8x notional) for 3–9 months to isolate scale/operational-leverage outperformance. Expect 10–20% relative outperformance if scale-driven margin capture persists; risk is category-wide traffic rebound which would hurt the short.
• Event trade: Buy on any post-earnings pullback >8% within 7 trading days and trim into strength around 15–25% move. Rationale: short-term volatility often misprices durable buyback/dividend optionality — reward if management accelerates capital returns, downside if guidance materially weakens.